Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays

Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays

Abstract There is a plethora of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) serological tests based either on nucleocapsid phosphoprotein (N), S1-subunit of spike glycoprotein (S1) or receptor binding domain (RBD). Although these single-antigen based tests demonstrate high clinical...

Full description

Saved in:
Bibliographic Details
Main Authors: Christos Fotis, Nikolaos Meimetis, Nikos Tsolakos, Marianna Politou, Karolina Akinosoglou, Vaia Pliaka, Angeliki Minia, Evangelos Terpos, Ioannis P. Trougakos, Andreas Mentis, Markos Marangos, George Panayiotakopoulos, Meletios A. Dimopoulos, Charalampos Gogos, Alexandros Spyridonidis, Leonidas G. Alexopoulos
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/858a40ad7d234e85a90d69d2e74774df
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/858a40ad7d234e85a90d69d2e74774df

Similar Items